Species. Penicillins Against Escherichia coli and Proteus. In Vitro Activity of Cephalothin and Three

Size: px
Start display at page:

Download "Species. Penicillins Against Escherichia coli and Proteus. In Vitro Activity of Cephalothin and Three"

Transcription

1 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Sept. 1973, p Copyright 1973 American Society for Microbiology Vol. 4, No. 3 Printed in U.S.A. In Vitro Activity of Cephalothin and Three Penicillins Against Escherichia coli and Proteus Species ARTHUR L. BARRY AND PAUL D. HOEPRICH Section of Infectious and Immunologic Diseases, Department of Internal Medicine, School of Medicine, University of California, Davis, California Received for publication 3 May 1973 The susceptibility of clinical isolates of Escherichia coli (67) and Proteus species (58) to cephalothin, ampicillin, benzyl penicillin, and phenoxymethyl penicillin was determined in vitro by using broth dilution and disk diffusion tests. The data were correlated by using a four-category scheme for interpreting minimal inhibitory concentrations (groups 1 to 4) as recommended by a subcommittee of an international collaborative study of susceptibility testing. With cephalothin and ampicillin, groups 1 (susceptible) and 2 (moderately susceptible) were susceptible by the disk test, and with benzyl penicillin, similar results were observed when the interpretive zone standards were changed. Strains categorized as group 4 (very resistant) were resistant by the disk method, but group 3 (moderately resistant) strains were not adequately distinguished by disk testing. Group 3 susceptibility to benzyl and phenoxymethyl penicillins can be predicted by extrapolating results from tests with ampicillin disks. At relatively high concentrations, the penicillins are active against many of the enteric previously described by Ericsson et al. (4). Four laborative study (5) and approved the concept bacilli. The closely related cephalosporins are categories of susceptibility (groups 1 to 4) were generally active against Escherichia coli and defined as follows. "Group 1 should include Proteus mirabilis, but not against the indolepositive species of Proteus. With the standard in vivo response probable when mild to moder- high degrees of bacterial sensitivity that makes disk method of Bauer et al. (2) as outlined by ately severe systemic infections are treated with the Food and Drug Administration (6), most usual dosages of antibiotic." This would be the strains of E. coli and of P. mirabilis would be oral route when applicable (e.g., ampicillin). considered susceptible to ampicillin, but not Group 1 can be defined as "sensitive" without susceptible to benzyl penicillin (penicillin G). further qualification. Group 1 might include However, if massive doses are applied in therapy, it is possible to obtain such high concentration (MIC) no greater than.25 gg of benzyl strains with a minimal inhibitory concentrations in the blood and other body fluids that penicillin per ml, 2 Ag of ampicillin per ml, or 4 successful treatment of infections caused by,gg of cephalothin per ml. "Group 2 should those enteric bacilli which are only moderately include degrees of sensitivity which make in susceptible to the penicillins may result (8). vivo response probable in systemic infections Lower-urinary-tract infections caused by enteric bacilli that are resistant to concentrations to the limits of toxicity." Group 2 might include when the antibiotic is given in high dosage or up ordinarily attained in the blood may respond to strains with MICs as great as 16,ug of benzyl treatment with either benzyl or phenoxymethyl penicillin or ampicillin per ml or 32 gg of penicillin, because these drugs are excreted into cephalothin per ml. Group 3 might include the urine, often attaining very high concentrations (7). Consequently, a reevaluation of the ml for all three drugs-that is, "degrees of bacteria with MICs no greater than 128 yg per standards for interpretating in vitro susceptibility tests is appropriate. ble in the treatment of localized infections at sensitivity,which make in vivo response proba- Recently, a subcommittee on interpretation sites where the agent can be concentrated by reviewed the subject for an international col- physiological processes or local application." 354 Downloaded from on June 3, 218 by guest

2 VOL. 4, 1973 Group 4 includes bacteria with MICs greater than 128 ug per ml, i.e., "... a degree of resistance which makes in vivo response improbable." The interpretive standards for categorization of susceptibility to phenoxymethyl penicillin (penicillin V) should be about the same as that for benzyl penicillin, but the upper limit dividing groups 3 and 4 might be greater, because a given oral dose of phenoxymethyl penicillin will yield a concentration in the urine at least twice that obtained with the same oral dose of benzyl penicillin (3). The current study was undertaken for two purposes. The first was to compare, in vitro, the relative activity of cephalothin, ampicillin, benzyl penicillin, and phenoxymethyl penicillin against recent clinical isolates of E. coli and Proteus species. For this purpose, the drugs were diluted so as to permit comparison on an equimolar basis; bactericidal as well as bacteriostatic end points were determined. Secondly, disk diffusion tests were performed to determine whether different levels of susceptibility could be distinguished by using commercially available disks. It was found that zones around disks containing 1,g of ampicillin could be used to predict group 3 susceptibility to benzyl penicillin and phenoxymethyl penicillin, whereas disks containing 1 U (6.3 gg) of benzyl penicillin were unsatisfactory for this purpose. The interpretation of in vitro tests with benzyl penicillin was reexamined, and new interpretive zone standards are proposed for gram-negative bacilli. MATERIALS AND METHODS The clinical isolates used for testing included 67 E. coli, 37 P. mirabilis, 7 Proteus vulgaris, 7 Proteus rettgeri, and 7 Proteus morganii strains. Disk diffusion tests were performed with the agar overlay technique (1), as recommended by the Food and Drug Administration (6), by using commercially available (Pfizer) disks containing 1 U (6.3 Mg) of benzyl penicillin, 1 Ag of ampicillin; and 3,gg of cephalothin. Dilution tests were carried out in Mueller-Hinton broth with a microbroth dilution technique by using a Mini-titer apparatus (Canalco Co., Rockville, Md.) to prepare doubling dilutions in.5-ml volumes. The dilution of 1 Mmol per ml (i.e., Ag [521.7 U] of benzyl penicillin, 35.4 Ag of phenoxymethyl penicillin, gg of ampicillin, and ug of cephalothin). Molar definition of concentrations was selected because the differences in molecular weights ranged from a low with benzyl-phenoxymethyl penicillins (phenoxymethyl is 4.8% heavier than benzyl penicillin) to a high with benzyl penicillin-cephalothin (cephalothin is 18.5% heavier than benzyl penicillin). The inoculum consisted of.5 ml of a 1-4 dilution of an ovemight culture in Mueller-Hinton broth. The IN VITRO ACTIVITY OF CEPHALOTHIN 355 MIC was determined after overnight incubation at 35 C, and the minimal lethal concentration was determined by subculturing approximately.1 ml (hand-held replicator) to Mueller-Hinton agar without antimicrobics. The minimal lethal (bactericidal) concentration was taken as the lowest concentration which failed to produce any colonies within 24 h after subculturing in this manner. RESULTS Broth dilution tests. The in vitro activity of the four drugs under study is summarized in Fig. 1. Against E. coli and P. mirabilis, benzyl penicillin was more active than phenoxymethyl penicillin, but both penicillins were relatively inactive against the indole-positive species of Proteus. Ampicillin was significantly more active than the other penicillins against E. coli and all four species of Proteus. A few indolepositive Proteus species were inhibited by relatively low concentrations of the penicillins (particularly ampicillin), but all required very high concentrations for a bactericidal effect. With E. coli and P. mirabilis all four drugs were lethal at concentrations generally equal to or one doubling dilution greater than the MIC. Against P. mirabilis, cephalothin had about the same activity as benzyl penicillin. When tested against ampicillin-susceptible E. coli, cephalothin had an activity about equal to that of ampicillin. Cephalothin was also effective against all but three of the ampicillin-resistant isolates included in this study. Cephalothin disk tests. The results of cephalothin disk diffusion and broth dilution tests are compared in Fig. 2. The interpretative zone standards established for the disk diffusion technique (6) classify microorganisms as being susceptible if the zone of inhibition is 18 mm or more; this correlates with MIC of 32,g per ml, which represents an appropriate break point between the moderately susceptible group 2 and moderately resistant group 3 bacteria. Most of the highly resistant strains in group 4 gave zones less than 14 mm, whereas most of the moderately resistant group 3 isolates gave zones greater than 14 mm. Consequently, the disk diffusion technique is capable of predicting the moderate susceptibility of E. coli and Proteus species to cephalothin, but does not adequately distinguish between group 2 and group 3. Alterations of the interpretive standards would not improve the correlation. The overall incidence of error with cephalothin disk tests is rather low (11 "errors" out of 127 tests). Ampicillin disk tests. Disk diffusion tests with 1-Mg ampicillin disk are compared with broth dilution tests in Fig. 3. Two distinct Downloaded from on June 3, 218 by guest

3 356 BARRY AND HOEPRICH a (m w I- n wlj Cl) - Cl) IL -J w I-. 4 a U MINIMAL CONCENTRATIONS INHIBITORY LETHAL Escherichia coli (67 isolates) Proteus species, indole +(21 isolates) 7 AMP x o----o CCEPH :-H - PEN G.. PEN V IF. I ^.-tsss*sf~~~ t co C o6 od If) X O O (D CD If) N N o - o o o ANTIMICROBIC CONCENTRATIONS, JAmole/mi FIG. 1. Relative activity of cephalothin (CEPH), ampicillin (AMP), benzyl penicillin (PEN G), and phenoxymethyl penicillin (PEN V) against Escherichia coli (67 isolates) and Proteus species (58 isolates). populations were demarcated by the 14 mm or greater zone size currently accepted (6) as indicating susceptibility (a MIC < 32 ug per ml). Those bacteria which fell into the susceptible groups 1 and 2 gave zones 14 mm in diameter or greater, whereas all but three of the resistant group 4 bacteria gave no zone of inhibition. Most of the isolates which would be considered only moderately resistant (group 3) were also susceptible by the disk diffusion technique. The accuracy of the disk test would PI I 1 I-~~ I1 1 ANTIMICROB. AG. CHEMOTHER. ll be improved if the upper limit dividing groups 2 and 3 were changed from 16 to 32 yg/ml, but such a change would not be justified by the data included in this report. Benzyl penicillin disk tests. Disks containing 1 U (6.3 1g) of benzyl penicillin were also tested, and the resulting zones were compared with broth dilution studies (Fig. 4). P. mnirabilis, with the only isolates that gave zones of inhibition that were 14 mm or greater, were all fairly susceptible (group 2). The current zone Downloaded from on June 3, 218 by guest

4 VOL. 4, 1973 IN VITRO ACTIVITY OF CEPHALOTHIN 357 i) Ag/ml Uimole/ml >396.4 > z S _ z _ _ T _ j _ X _ 1I 6 1 ZONE DIAMI FIG. 2. Relationship of d1isk diffusion and discs) broth both cases, group 1 and 2 gram-negative bacilli dilution tests with cephalot hin against Escherichia are included in the "susceptible" category. coli and Proteus spp. The reg. ression formula Y = MIC There was no inhibition with the moderately in log., Aglml (i.e., Y = 1.2!to.3x) was used. resistant group 3 bacteria that might respond to treatment when very high concentrations of the AMPICILLIN drug can be maintained at the site of infections. z Ag/mi.mole/nml B367 4 >IO C I z I_ u I _ of I Ia _ I _ z.7.2 F.4.1 _ LI.L...I j,g/mi Jimole/ml z>334.4 > 1. F _ l w CEPHALOTHIN 21 mm in diameter. This end point is * Escherichia coil (67) unsatisoprotu miroilis (39) factory, because it would cut through the center ProtMus sp., MM/ #,(2)/ of of 39 fairly susceptible (group 2) P. * & GROUP4 mirabilis. The interpretative zone standards ~~~GROUP 3 1GRO3 established for ampicillin would be more appro- priate for testing benzyl penicillin disks against 1^ GROUP28 the enteric bacilli; i.e., susceptible is defined as ^-*ne<s C 14 mm or larger and resistant as 11 mm or less. I- -I--- - With this change, the group 2 isolates would be l CD reported to be susceptible to benzyl penicillin GROUP by the disk method. Such a redefinition of Il t susceptibility would yield results more consist- E5ERS IN ent with those observed with ampicillin; i.e., in Nmm 13 jig * Eschorichia coti (67) For this the 1-U benzyl penicillin disk Prot*us s,irahi/is (39) a Prote/s sp., Indole *(2/) is unsatisfactory. GROUP 4 Because disks with a higher content of benzyl penicillin and disks. containing phenoxymethyl I * GROUP 3 penicillin are not available commercially, a -- practical altemative method was sought for GROUP 2 predicting high-level susceptibility to benzyl.,} and phenoxymethyl penicillins. A direct com- -o parison between MIC values for ampicillin and GROUP benzyl penicillin demonstrated an excellent 6 1 IS ~ 3 ZONE IAMWETERS IN (IOAig discs) correlation, although MICs for ampicillin tended to be about two doubling dilutions lower FIG. 3. Relationship of diisk diffusion and broth than those for benzyl penicillin. Accordingly, dilution tests with ampicillin against Escherichia coli the data were examined to determine if it would and Proteus species. The regr ession formula Y = MIC be feasible to predict susceptibility to benzyl or in log2, ug/ml (i.e., Y = 1. to.35x) was used. phenoxymethyl penicillins, or both, by using disks containing the more active ampicillin. 8ENZYL PENICILLIN Prediction of susceptibility to benzyl peni- * Escherichia co/i (67) cillin and phenoxymethyl penicillin Proteus reirohilis (39) Protes Sp.; /do/ + (2/) by using 1-.g ampicillin disks. In Fig. 5, broth dilution tests with benzyl penicillin and with phenoxymethyl penicillin are compared with diameters I* GROUP 3 of zones of inhibition obtained with 1-,ug am- > _ Fe picillin disks. The moderately resistant, group 3 We E. coli that gave no zones of inhibition with z o benzyl penicillin disks gave zones greater than a mm with ampicillin disks. The moderately z.65.2 susceptible group 2 P. mirabilis gave much I I! 2I 1O larger zones (21 mm or 15 greater) ZONE DIAMETERS IN mm (1 unit discs) Phenoxymethyl penicillin was less active in FIG. 4. Relationship of diisk diffusion and broth vitro, and a 14-mm zone around a 1-t.g amdilution tests with benzyl pienicillin against Esche- picillin disk correlated with an MIC of 218,ug richia coli and Proteus specie?s. per ml, whereas a 21-mm zone correlated with an MIC of 96,ug per ml. If the break point between group 3 and group 4 were placed at size standards for benzyl Ipenicillin (6) consider 256,ug per ml, most strains which are suscepti- to be suscep- ble to ampicillin by the disk method (14 mm or bacteria other than staphsylococci tible if the zone diameter iis 22 mm or more and more) should be moderately resistant to phelity if the zone is 12 to noxymethyl penicillin (group 3). The intermediate in susceptibi: highly Downloaded from on June 3, 218 by guest

5 358 BARRY AND HOEPRICH ANTIMICROB. AG. CHEMOTHER. jig/ml >334.4 cn z *<, 83.6 Z N o 1.4 o a] 5.2 o 2.6 I Z >35 J 35 )Lmole/ml > > * Escherichio co/i (67) o Proteus mirabi/is (39).1i6 Proteus sp., Indole +.21) 16 \ ^GROUP 4 s 1X* -o 1 UstI _ WI 3 6 GROUP3 - *1 _.3 6 o _- o o 88 ~~~~~~ oso _ 8 R GROUP 2 I o o X > I I I I >3 ZONE DIAMETERS IN mm (IoAxg AMPICILLIN discs) FIG. 5. Prediction of the susceptibility of Escherichia coli and Proteus species to benzyl and phenoxymethyl penicillins by using ampicillin disks. resistant group 4 strains give no zone around ampicillin disks. DISCUSSION Once the etiologic agent has been identified, the most appropriate antimicrobial agent for treatment can be selected by considering the severity and location of the infection and the pharmacological properties of the various potentially useful drugs. Data of the sort presented in this report can be used to estimate the approximate concentration of drug that would be needed to effect a cure of infections caused by E. coli or Proteus species. For example, isolates of P. mirabilis are more susceptible to the penicillins than most E. coli; the three indole-positive species of Proteus are even more resistant. However, resistant strains of P. mirabilis are encountered often enough to warrant the performance of susceptibility tests with each isolate. This can be done most efficiently with the standard disk diffusion methods that classify bacteria into one of two categories (susceptible or resistant), with an intermediate category which includes tests with indeterminate or equivocal results. In practice, very few isolates will give zones in the equivocal range if * z a 175 3, 87.6 E 43.8 o 21.9 *I GROUP 4 I'* a -co * GROUP 3 IIt I o 8 o 88B - the zone size break points fall at loci between two distinct populations, i.e., when there is a clear bimodal distribution of zone diameters.. Such a bimodal distribution is not evident with the drugs and genera under discussion, and thus some equivocal results are to be expected with the disk test. The intermediate category actually serves as a "buffer" zone between the two categories and helps to minimize the importance of relatively minor variations in technique which could influence the zone size enough to alter interpretation from resistant or from susceptible to intermediate (equivocal) strains rather than from resistant to susceptible strains. With benzyl penicillin, the intermediate category has been assigned a uniquely different meaning: a rather wide zone limit has been established (12 to 21 mm) to include those strains which are neither truly resistant nor fully susceptible, i.e., group 2 strains which would not respond to dosages normally used for treating highly susceptible genera such as Streptococcus pneumoniae. Moderately resistant group 3 strains are not separated from the very resistant group 4 strains as is done with other antimicrobics-instead both are considered resistant. Ta3 o... Downloaded from on June 3, 218 by guest

6 VOL. 4, 1973 IN VITRO ACTIVITY OF CEPHALOTHIN 359 The interpretive zone standards for the disk test are established after examining the correlation between zone diameters and MIC values. The MICs, in turn, may be interpreted according to the approximate concentration of drug that can be maintained at the site of the infection with the dosage schedule normally used for the type of infection and type of organism being treated. Because of the latter qualification, the criterion for defining susceptibility of one genus may differ from that used to classify another genus when different dosage schedules are recommended for the two genera. Consequently, the division of susceptible organisms into groups 1 and 2 is not essential, because the level of susceptibility (dosage normally required for therapy) for a given genus is cons,idered in establishing the interpretive standards. For the gram-negative enteric bacilli, susceptibility to benzyl penicillin could be redefined as an MIC of 16 Ag/ml or less (zone of 14 mm or greater). With such a classification most strains of P. mirabilis would be susceptible, whereas other Proteus species and E. coli would be resistant. Because P. mirabilis infections appear to respond to treatment with benzyl penicillin in doses greater than those normally used for more susceptible organisms, such a reclassification would seem to be appropriate. The currently recommended (6) zone standards are unsatisfactory, because about half of our isolates of P. mirabilis would have been reported to be susceptible to benzyl penicillin and the other half intermediate in susceptibility, irrespective of MICs. At the same time, most strains of P. mirabilis would be reported to be fully susceptible to ampicillin, although appropriate doses of either drug would produce blood levels well above the expected MIC values. Certain strains which are normally considered resistant might respond to therapy under certain circumstances. For example, in the treatment of urinary tract infections, the concentration of certain drugs at the site of infection might greatly exceed that normally found in the serum. Furthermore, in the treatment of systemic infections with relatively nontoxic drugs such as the penicillins, the average bloed levels can be exceeded by administering massive doses. Consequently, it would seem advisable to develop a test system which would distinguish those resistant strains which might respond under such circumstances (group 3) from the group 4 strains which are highly resistant, and thus not likely to respond. With ampicillin and cephalothin, the resistant group 4 bacteria were clearly resistant by the disk method, but the less resistant group 3 isolates presented some discrepancies. With these two drugs, the few strains which fell into the group 3 category gave zones in all three established ranges of susceptibility (fewest in the intermediate range). With benzyl penicillin disks, groups 3 and 4 gave no zone of inhibition and thus could not be distinguished. However, a 1-,Ag ampicillin disk would distinguish the slightly susceptible group 3 bacteria from the more resistant group 4 strains. Phenoxymethyl penicillin was the least active drug included in the present study and is probably inappropriate for treating gram-negative bacillary infections, except in situations where very high concentrations can be expected, e.g., in the urine. Thus, a group 3 category of susceptibility may be appropriate for the gram-negative bacilli. Those strains which are susceptible to ampicillin by the disk method will be slightly susceptible to phenoxymethyl penicillin and should respond in cases where the concentration can be expected to exceed 25jug/ml. On the other hand, ampicillin-resistant strains should not respond, even to these extremely high concentrations of phenoxymethyl penicillin. In actual practice, considerable information can be obtained from tests with ampicillin disks alone. Gram-negative bacilli that give zones greater than 21 mm in diameter are quite susceptible (groups 1 and 2) to ampicillin, moderately susceptible (group 2) to benzyl penicillin, and slightly susceptible (group 3) to phenoxymethyl penicillin. Strains that give zones between 14 and 2 mm are likely to be somewhat less susceptible to all three drugs. Isolates that give zones less than 11 mm in diameter around ampicillin disks are likely to be highly resistant to all three penicillins, but are often susceptible to the cephalosporins. ACKNOWLEDGMENTS The technical aid of Allen P. Adams is gratefully acknowledged. This study was supported in part by Public Health Service grants AI-8955 and AI-384 from the National Institute of Allergy and Infectious Diseases. LITERATURE CITED 1. Barry, A. L., F. Garcia, and L. D. Thrupp An improved single-disc method for testing the antibiotic susceptibility of rapidly growing pathogens. Amer. J. Clin. Pathol. 53: Bauer, A. W., W. M. M. Kirby, J. C. Sherris, and M. Turck Antibiotic susceptibility testing by a standardized single disc method. Amer. J. Clin. Pathol. 45: Cox, F., J. M. Colville, J. Truant, and E. L. Quinn Further observations on the use of large doses of oral Downloaded from on June 3, 218 by guest

7 36 BARRY AND HOEPRICH penicillin V. (phenoxymethyl penicillin). Antibiot. Annu : Ericsson, H., G. Tunevall, and K. Wickman The paper disc method for determination of bacterial sensitivity to antibiotics. Scand. J. Clin. Lab. Invest. 12: Ericsson, H. M., and J. C. Sherris Antibiotic sensitivity testing, report of an intemational collaborative study. Acta Pathol. Microbiol. Scand. Suppl. no. 217, sect. B: 3-9. ANTIMICROB. AG. CHEMOTHER. 6. Fine, S. D Antibiotic susceptibility discs; certification procedure. Fed. Reg. 37: (191). 7. Stamey, T. A., D. E. Govan, and J. M. Palmer The localization and treatment of urinary tract infections: the role of bactericidal urine levels as opposed to serum levels. Medicine 44: Weinstein, L., P. I. Lerner, and W. H. Chew Clinical and bacteriologic studies of the effect of "massive" doses of penicillin G and infections caused by gram negative bacilli. N. Engl. J. Med. 271: Downloaded from on June 3, 218 by guest

Sensitivity of Gram-negative bacilli to ampicillin

Sensitivity of Gram-negative bacilli to ampicillin J. clin. Path. (1969), 22, 644-648 Sensitivity of Gram-negative bacilli to ampicillin after six years' clinical use B. SLOCOMBE AND R. SUTHERLAND From Beecham Research Laboratories, Brockham Park, Betchworth,

More information

Against Aerobic Gram-Negative Bacilli

Against Aerobic Gram-Negative Bacilli ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Dec. 1979, p. 6-6 0066-0/79/1-06/05$0.00/0 Vol., No. 6 In Vitro Activity of LY17935, a New 1-Oxa Cephalosporin, Against Aerobic Gram-Negative Bacilli DENNIS G. DELGADO,

More information

Rifampin Resistance. Charlottesville, Virginia i0w organisms in Trypticase soy broth (BBL Microbiology

Rifampin Resistance. Charlottesville, Virginia i0w organisms in Trypticase soy broth (BBL Microbiology ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Apr. 1980, p. 658-662 0066-4804/80/04-0658/05$02.00/0 Vol. 17, No. 14 Treatment of Experimental Staphylococcal Infections: Effect of Rifampin Alone and in Combination

More information

Synergism of Fosfomycin-Ampicillin and Fosfomycin-

Synergism of Fosfomycin-Ampicillin and Fosfomycin- ANTIMICROBiAL AGENTS AND CHEMoTHERAPY, May 1978, p. 75-79 66-484/78/13-75$2./ Copyright 1978 American Society for Microbiology Vol. 13, No. 5 Printed in U.S.A. Synergism of Fosfomycin-Ampicillin and Fosfomycin-

More information

UTI : A NEW APPROACH TO ITS DIAGNOSIS

UTI : A NEW APPROACH TO ITS DIAGNOSIS Abstract UTI : A NEW APPROACH TO ITS DIAGNOSIS Pages with reference to book, From 126 To 129 S. Hafiz, N. Lyall ( Department of Microbiology, The Aga Khan University Hospital, Karachi. ) The incidence

More information

Affinity of Doripenem and Comparators to Penicillin-Binding Proteins in Escherichia coli and ACCEPTED

Affinity of Doripenem and Comparators to Penicillin-Binding Proteins in Escherichia coli and ACCEPTED AAC Accepts, published online ahead of print on February 00 Antimicrob. Agents Chemother. doi:./aac.01-0 Copyright 00, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights

More information

Susceptibility of Cephalothin-Resistant Gram-Negative Bacilli

Susceptibility of Cephalothin-Resistant Gram-Negative Bacilli ANTIMICROBIAL AGENTS AND CHEmOTHERAPY, Mar. 1978, p. 484489 0066-4804/8/0013-0484$02.00/0 Copyright 1978 American Society for Microbiology Vol. 13, No. 3 Printed in U.S.A. Susceptibility of Cephalothin-Resistant

More information

Enhancing Effect on Alkalinization of the Medium

Enhancing Effect on Alkalinization of the Medium Appum MICROBIOLOGY, Sept. 968, p. 88-9 Copyright @ 968 American Society for Microbiology Vol. 6, No. 9 Printed in U.S.A. Enhancing Effect on Alkalinization of the Medium on the Activity of Erythromycin

More information

Acceptability of Sputum Specimens

Acceptability of Sputum Specimens JOURNAL OF CLINICAL MICROBIOLOGY, Oct. 1982, p. 627-631 0095-1137/82/100627-05$02.00/0 Copyright C 1982, American Society for Microbiology Vol. 16, No. 4 Comparison of Six Different Criteria for Judging

More information

Evaluation of Antibacterial Effect of Odor Eliminating Compounds

Evaluation of Antibacterial Effect of Odor Eliminating Compounds Evaluation of Antibacterial Effect of Odor Eliminating Compounds Yuan Zeng, Bingyu Li, Anwar Kalalah, Sang-Jin Suh, and S.S. Ditchkoff Summary Antibiotic activity of ten commercially available odor eliminating

More information

CHAPTER 8 ANTIBACTERIAL ACTIVITY OF THE CRUDE ETHANOLIC EXTRACT AND THE ISOLATED COMPOUNDS FROM THE STEM OF COSTUS IGNEUS

CHAPTER 8 ANTIBACTERIAL ACTIVITY OF THE CRUDE ETHANOLIC EXTRACT AND THE ISOLATED COMPOUNDS FROM THE STEM OF COSTUS IGNEUS CHAPTER 8 ANTIBACTERIAL ACTIVITY OF THE CRUDE ETHANOLIC EXTRACT AND THE ISOLATED COMPOUNDS FROM THE STEM OF COSTUS IGNEUS 8.1 INTRODUCTION Medicinal plants are the backbone of traditional medicine and

More information

Treatment of serious Pseudomonas infections with azlocillin

Treatment of serious Pseudomonas infections with azlocillin Journal of Antimicrobial Chemotherapy (983), Suppl. B, 53-58 Treatment of serious Pseudomonas infections with azlocillin S. Olive, W. J. Mogabgab, B. Holmes, B. Pollock, B. Pauling and R. Beville Tulane

More information

Comparison Between Agar and Broth Minimum Inhibitory Concentrations of Cefamandole, Cefoxitin, and Cefuroxime

Comparison Between Agar and Broth Minimum Inhibitory Concentrations of Cefamandole, Cefoxitin, and Cefuroxime ANTMCROBAL AGENTS AND CHEMOTHERAPY, Apr 1979, p 572-579 0066-4804/79/00572/08$0200/0 Vol 15, No4 Comparison Between Agar and Broth Minimum nhibitory Concentrations of Cefamandole, Cefoxitin, and Cefuroxime

More information

Prevalence of Extended Spectrum -Lactamases In E.coli and Klebsiella spp. in a Tertiary Care Hospital

Prevalence of Extended Spectrum -Lactamases In E.coli and Klebsiella spp. in a Tertiary Care Hospital ISSN: 2319-7706 Volume 3 Number 10 (2014) pp. 474-478 http://www.ijcmas.com Original Research Article Prevalence of Extended Spectrum -Lactamases In E.coli and Klebsiella spp. in a Tertiary Care Hospital

More information

Experimental Endocarditis Caused by Streptococcus sanguis:

Experimental Endocarditis Caused by Streptococcus sanguis: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, July 1981, p. 1-14 66-484/81/71-5$2./ Vol. 2, No. 1 Experimental Endocarditis Caused by Streptococcus sanguis: Single and Combined Antibiotic Therapy MARIA V. VICENTE,

More information

Steven D. Brown* and Maria M. Traczewski. The Clinical Microbiology Institute, 9725 SW Commerce Circle, Wilsonville, Oregon 97070

Steven D. Brown* and Maria M. Traczewski. The Clinical Microbiology Institute, 9725 SW Commerce Circle, Wilsonville, Oregon 97070 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, May 2010, p. 2063 2069 Vol. 54, No. 5 0066-4804/10/$12.00 doi:10.1128/aac.01569-09 Copyright 2010, American Society for Microbiology. All Rights Reserved. Comparative

More information

Determination of MIC & MBC

Determination of MIC & MBC 1 Determination of MIC & MBC Minimum inhibitory concentrations (MICs) are defined as the lowest concentration of an antimicrobial that will inhibit the visible growth of a microorganism after overnight

More information

ACCEPTED. Comparison of disk diffusion and agar dilution methods for erythromycin and

ACCEPTED. Comparison of disk diffusion and agar dilution methods for erythromycin and AAC Accepts, published online ahead of print on January 00 Antimicrob. Agents Chemother. doi:./aac.000-0 Copyright 00, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights

More information

Clinical Comparison of Cefotaxime with Gentamicin plus Clindamycin in the Treatment of Peritonitis and Other Soft-Tissue Infections

Clinical Comparison of Cefotaxime with Gentamicin plus Clindamycin in the Treatment of Peritonitis and Other Soft-Tissue Infections REVIEWS OF INFECTIOUS DISEASES. VOL. 4, SUPPLEMENT. SEPTEMBER-OCTOBER 982 982 by The University of Chicago. All rights reserved. 062-0886/82/0405-022$02.00 Clinical Comparison of with Gentamicin plus Clindamycin

More information

Haemophilus influenzae from four laboratories in one Canadian City

Haemophilus influenzae from four laboratories in one Canadian City Journal of Antimicrobial Chemotherapy (988), -9 Haemophilus influenzae from four laboratories in one Canadian City Julie Righter" and Ingrid Luchstnger* 'Department of Microbiology, University of Toronto;

More information

Analysis of Rifampin Disk Diffusion and Stability in 7H10 Agar

Analysis of Rifampin Disk Diffusion and Stability in 7H10 Agar ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Aug. 1975, p. 187-193 Copyright i 1975 American Society for Microbiology Vol. 8, No. 2 Printed in U.SA. Analysis of Rifampin Disk Diffusion and Stability in 7H1 Agar

More information

Received 30 March 2005; returned 16 June 2005; revised 8 September 2005; accepted 12 September 2005

Received 30 March 2005; returned 16 June 2005; revised 8 September 2005; accepted 12 September 2005 Journal of Antimicrobial Chemotherapy (2005) 56, 1047 1052 doi:10.1093/jac/dki362 Advance Access publication 20 October 2005 Evaluation of PPI-0903M (T91825), a novel cephalosporin: bactericidal activity,

More information

AN ASSESSMENT OF AMPICILLIN IN THE TREATMENT OF URINARY TRACT INFECTION

AN ASSESSMENT OF AMPICILLIN IN THE TREATMENT OF URINARY TRACT INFECTION Urinary Tract Infections AN ASSESSMENT OF AMPICILLIN IN THE TREATMENT OF URINARY TRACT INFECTION W. BRUMFITT, D. A. LEIGH, A. PERCIVAL and J. D. WILLIAMS. Edgware General Hospital, Edgware, Middlesex.

More information

Antimicrobial activity of Terminalia chebula

Antimicrobial activity of Terminalia chebula , ISSN 2249 4340 Vol. 1, No. 2, pp. 175-179, September 2011 RESEARCH ARTICLE Antimicrobial activity of Terminalia chebula M. Golam MOSTAFA, Mahdia RAHMAN, M. Manjurul KARIM* Department of Microbiology,

More information

Cefuroxime iv Rationale for the EUCAST clinical breakpoints, version th September 2010

Cefuroxime iv Rationale for the EUCAST clinical breakpoints, version th September 2010 Cefuroxime iv Rationale for the EUCAST clinical breakpoints, version 1.0 26 th September 2010 Foreword EUCAST The European Committee on Antimicrobial Susceptibility Testing (EUCAST) is organised by the

More information

Cefotaxime Rationale for the EUCAST clinical breakpoints, version th September 2010

Cefotaxime Rationale for the EUCAST clinical breakpoints, version th September 2010 Cefotaxime Rationale for the EUCAST clinical breakpoints, version 1.0 26 th September 2010 Foreword EUCAST The European Committee on Antimicrobial Susceptibility Testing (EUCAST) is organised by the European

More information

OUTLINE Laboratory Detection and Reporting of Streptococcus agalactiae

OUTLINE Laboratory Detection and Reporting of Streptococcus agalactiae OUTLINE Laboratory Detection and Reporting of Streptococcus agalactiae I. Importance of prenatal screening strategies II. Past approaches Erik Munson Clinical Microbiology Wheaton Franciscan Laboratory

More information

A new selective blood agar medium for Streptococcus pyogenes and other haemolytic streptococci

A new selective blood agar medium for Streptococcus pyogenes and other haemolytic streptococci J. clin. Path. (1964), 17, 231 A new selective blood agar medium for Streptococcus pyogenes and other haemolytic streptococci E. J. L. LOWBURY, A. KIDSON, AND H. A. LILLY From the Medical Research Council

More information

Laboratory Detection and Reporting of Streptococcus agalactiae

Laboratory Detection and Reporting of Streptococcus agalactiae Laboratory Detection and Reporting of Streptococcus agalactiae Erik Munson Clinical Microbiology Wheaton Franciscan Laboratory Milwaukee, Wisconsin The presenter states no conflict of interest and has

More information

THE "REVERSAL," NEUTRALIZATION, AND SELECTIVITY

THE REVERSAL, NEUTRALIZATION, AND SELECTIVITY THE "REVERSAL," NEUTRALIZATION, AND SELECTIVITY OF GERMICIDAL CATIONIC DETERGENTS' MORTON KLEIN AND ZELMA G. KARDON Department of Bacteriology, School of Medicine, University of Pennsylvania, Philadelphia

More information

HOSPITAL EPIDEMOLOGY AND INFECTION CONTROL: STANDARD AND TRANSMISSION-BASED ISOLATION

HOSPITAL EPIDEMOLOGY AND INFECTION CONTROL: STANDARD AND TRANSMISSION-BASED ISOLATION Appendix 1: Carbapenem-Resistant Enterobacteriacaea (CRE) I. Definition: 2015 CDC definition of CRE are Enterobacteriaceae 1 that are: A. Resistant to any carbapenem antimicrobial (i.e., minimum inhibitory

More information

Laboratory assessment of physical and chemical methods of preserving urine specimens

Laboratory assessment of physical and chemical methods of preserving urine specimens J. clin. Path., 1977, 30, 532-536 Laboratory assessment of physical and chemical methods of preserving urine specimens P. G. WATSON AND B. I. DUERDEN' From the Department of Bacteriology, Edinburgh University

More information

Comparative Activity of Cefotaxime and Selected f3-lactam Antibiotics Against Haemophilus Influenzae and Aerobic Gram-Negative Bacilli

Comparative Activity of Cefotaxime and Selected f3-lactam Antibiotics Against Haemophilus Influenzae and Aerobic Gram-Negative Bacilli REVIEWS OF INFECTIOUS DISEASES VOL. 4, SUPPLEMENT SEPTEMBER-OCTOBER 1982 1982 by The University of Chicago. All rights reserved. 0162-0886/82/0405-0015$02.00 Comparative Activity of Cefotaxime and Selected

More information

Kyabaggu D, 2 Ejobi F 3* Olila D

Kyabaggu D, 2 Ejobi F 3* Olila D The sensitivities to first-line antibiotic therapy of the common urinary tract bacterial infections detected in urine samples at a hospital in metropolitan Kampala (Uganda) 1 Kyabaggu D, 2 Ejobi F 3* Olila

More information

The CLSI Approach to Setting Breakpoints

The CLSI Approach to Setting Breakpoints The CLSI Approach to Setting Breakpoints Jean B. Patel, PhD, D(ABMM) Deputy Director, Office of Antimicrobial Resistance Division of Healthcare Quality Promotion National Center for Emerging and Zoonotic

More information

RELATIONSHIP TO RESISTANCE IN KLEBSIELLA PNEUMONIAE

RELATIONSHIP TO RESISTANCE IN KLEBSIELLA PNEUMONIAE THE SIGNIFICANCE OF LACTOSE FERMENTATION AND ITS RELATIONSHIP TO RESISTANCE IN KLEBSIELLA PNEUMONIAE VICTOR J. CABELLI' AND M. J. PICKETT Department of Bacteriology, University of California, Los Angeles,

More information

Influence of Water Diuresis on Antimicrobial

Influence of Water Diuresis on Antimicrobial Influence of Water Diuresis on Antimicrobial Treatment of Enterococcal Pyelonephritis SANDRA P. LEVISON and DONALD KAYE From the Department of Medicine, The Medical College of Pennsylvania, Philadelphia,

More information

In vitro assessment of dual drug combinations to inhibit growth of Neisseria gonorrhoeae

In vitro assessment of dual drug combinations to inhibit growth of Neisseria gonorrhoeae AAC Accepted Manuscript Posted Online 26 January 2015 Antimicrob. Agents Chemother. doi:10.1128/aac.04127-14 Copyright 2015, American Society for Microbiology. All Rights Reserved. 1 2 In vitro assessment

More information

Comparision of Antibiotic Susceptibility Testing As Per CLSI and Eucast Guidelines for Gram Negative Bacilli

Comparision of Antibiotic Susceptibility Testing As Per CLSI and Eucast Guidelines for Gram Negative Bacilli IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 15, Issue 7 Ver. X (July. 2016), PP 01-05 www.iosrjournals.org Comparision of Antibiotic Susceptibility

More information

THE USE OF THE PENICILLINASE-RESISTANT

THE USE OF THE PENICILLINASE-RESISTANT Therapeutic problems THE USE OF THE PENICILLINASE-RESISTANT PENICILLIN IN THE PNEUMONIAS OF CHILDREN MARTHA D. Yow, MARY A. SOUTH AND CHARLES G. HESS From the Department of Pediatrics, Baylor University

More information

Received 21 April 1997/Returned for modification 30 June 1997/Accepted 28 August 1997

Received 21 April 1997/Returned for modification 30 June 1997/Accepted 28 August 1997 JOURNAL OF CLINICAL MICROBIOLOGY, Dec. 1997, p. 3258 3263 Vol. 35, No. 12 0095-1137/97/$04.00 0 Copyright 1997, American Society for Microbiology Comparison of Agar Dilution, Broth Microdilution, E-Test,

More information

R. B. VAUGHAN. M.B., B.S., Ph.D. Clinical Research Department, Pfizer Limited tion of the indanyl ester. Serum levels were also

R. B. VAUGHAN. M.B., B.S., Ph.D. Clinical Research Department, Pfizer Limited tion of the indanyl ester. Serum levels were also Postgraduate Medical Journal (July 1972) 48, 422-426. The pharmacokinetics of an oral form of carbenicillin in patients with renal failure R. R. BAILEY* M.D.(N.Z.), M.R.A.C.P., M.R.C.P. J. B. EASTWOOD

More information

INVESTIGATIONS ON RABBITS

INVESTIGATIONS ON RABBITS Meningitis THE PASSAGE OF PENICILLINS INTO THE CEREBRO-SPINAL FLUID AND BRAIN IN EXPERIMENTAL MENINGITIS-EXPERIMENTAL INVESTIGATIONS ON RABBITS THE majority of the experiments were made on adult rabbits.

More information

Cephalosporin, Against Cephalosporin-Resistant Bacteria, and

Cephalosporin, Against Cephalosporin-Resistant Bacteria, and ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Nov. 1979, P. 59-553 Vol. 16, No. 5 66-/79/11-59/$2./ Antibacterial Activity of Ceftizoxime (FK 79), a New Cephalosporin, Against Cephalosporin-Resistant Bacteria,

More information

COMPARATIVE ANTI MICROBIAL STUDY OF SHUDDHA KASISA AND KASISA BHASMA

COMPARATIVE ANTI MICROBIAL STUDY OF SHUDDHA KASISA AND KASISA BHASMA Research Article International Ayurvedic Medical Journal ISSN:2320 5091 COMPARATIVE ANTI MICROBIAL STUDY OF SHUDDHA KASISA AND KASISA BHASMA Dr. Nisha Kumari.P. R *Dr. Dinesh Nayak J **, Dr. Sathyanarayana

More information

Clinical and In Vitro Evaluation of Cefazolin, a New Cephalosporin Antibiotic

Clinical and In Vitro Evaluation of Cefazolin, a New Cephalosporin Antibiotic ANTMICROBIAL AGZNTS AND CHEMOTHERPY, Feb. 1973, p. 168174 Copyright 1973 American Society for Microbiology Vol. 3, No. 2 Printed in U.S.A. Clinical and In Vitro Evaluation of Cefazolin, a New Cephalosporin

More information

The activity of cefotaxime and desacetylcefotaxime against Bacteroides species compared to 7-methoxy cephems and other anti-anaerobe drugs

The activity of cefotaxime and desacetylcefotaxime against Bacteroides species compared to 7-methoxy cephems and other anti-anaerobe drugs Journal of Antimicrobial Chemotherapy (984) 4, Suppl. B, 39-43 The activity of cefotaxime and desacetylcefotaxime against Bacteroides species compared to 7-methoxy cephems and other anti-anaerobe drugs

More information

Cefadroxil for Oral Suspension USP 250 mg/5 ml and 500 mg/5 ml

Cefadroxil for Oral Suspension USP 250 mg/5 ml and 500 mg/5 ml Cefadroxil for Oral Suspension USP 250 mg/5 ml and 500 mg/5 ml Rx only To reduce the development of drug-resistant bacteria and maintain the effectiveness of cefadroxil for oral suspension and other antibacterial

More information

Int.J.Curr.Microbiol.App.Sci (2014) 3(3):

Int.J.Curr.Microbiol.App.Sci (2014) 3(3): ISSN: 2319-7706 Volume 3 Number 3 (2014) pp. 668-674 http://www.ijcmas.com Original Research Article Antibiotic resistant pattern of urinary tract infection causing Escherichia coli isolated from diabetic

More information

THE ADMINISTRATION OF CEPHRADINE TO PATIENTS IN RENAL FAILURE

THE ADMINISTRATION OF CEPHRADINE TO PATIENTS IN RENAL FAILURE Br. J. clin. Pharmac. (1975), 2, 3-8 THE ADINISTRATION O CEPHRADINE TO PATIENTS IN RENAL AILURE ANNE E. SOLOON & J.D. BRIGGS Renal Unit, Western Infirmary, Glasgow Gl1 6NT R. cgeachy & J.D. SLEIGH Department

More information

Efficacy of Ceftriaxone in Serious Bacterial Infections

Efficacy of Ceftriaxone in Serious Bacterial Infections ANTIMIROBIAL AGENTS AND HEMOTHERAPY, Mar 1982, p 402-406 0066-4804/82/030402-05$0200/0 Vol 21, No 3 Efficacy of eftriaxone in Serious Bacterial Infections JAY S EPSTEIN, SUSAN M HASSELQUIST, AND GARY L

More information

Adenium Biotech. Management: - Peter Nordkild, MD, CEO, ex Novo Nordisk, Ferring, Egalet - Søren Neve, PhD, project director, ex Lundbeck, Novozymes

Adenium Biotech. Management: - Peter Nordkild, MD, CEO, ex Novo Nordisk, Ferring, Egalet - Søren Neve, PhD, project director, ex Lundbeck, Novozymes Adenium Biotech Management: - Peter Nordkild, MD, CEO, ex Novo Nordisk, Ferring, Egalet - Søren Neve, PhD, project director, ex Lundbeck, Novozymes Board of Directors: - Stephan Christgau, PhD, chairman,

More information

Antiseptic and antibiotic resistance in Gram-negative bacteria causing urinary tract infection

Antiseptic and antibiotic resistance in Gram-negative bacteria causing urinary tract infection J Clin Patho/ 198; 33: 288-296 Antiseptic and antibiotic resistance in Gram-negative bacteria causing urinary tract infection DJ STICKLER AND B THOMAS From the Department of Applied Biology, University

More information

Pharmacologyonline 1: (2010) ewsletter Singh and Kochbar. Optimizing Pharmacokinetic/Pharmacodynamics Principles & Role of

Pharmacologyonline 1: (2010) ewsletter Singh and Kochbar. Optimizing Pharmacokinetic/Pharmacodynamics Principles & Role of Optimizing Pharmacokinetic/Pharmacodynamics Principles & Role of Cefoperazone Sulbactam Singh M*, Kochhar P* Medical & Research Division, Pfizer India. Summary Antimicrobial resistance is associated with

More information

/01/$ DOI: /JCM Copyright 2001, American Society for Microbiology. All Rights Reserved.

/01/$ DOI: /JCM Copyright 2001, American Society for Microbiology. All Rights Reserved. JOURNAL OF CLINICAL MICROBIOLOGY, Jan. 2001, p. 183 190 Vol. 39, No. 1 0095-1137/01/$04.00 0 DOI: 10.1128/JCM.39.1.183 190.2001 Copyright 2001, American Society for Microbiology. All Rights Reserved. Contemporary

More information

Clinical experience with ceftazidime in urology in Japan

Clinical experience with ceftazidime in urology in Japan Journal of Antimicrobial Chemotherapy (98), Suppl. A, 6- Clinical experience with ceftazidime in urology in Japan Noboo Kawamura Department of Urology, Tokai University, School of Medicine, Bosei-dai,

More information

Sensitivity of Surveillance Testing for Multidrug-Resistant Gram-Negative Bacteria in the

Sensitivity of Surveillance Testing for Multidrug-Resistant Gram-Negative Bacteria in the JCM Accepts, published online ahead of print on 20 August 2014 J. Clin. Microbiol. doi:10.1128/jcm.02369-14 Copyright 2014, American Society for Microbiology. All Rights Reserved. 1 2 Sensitivity of Surveillance

More information

Methods for colistin testing What works and what does not? Erika Matuschek, Ph D EUCAST Development Laboratory, EDL

Methods for colistin testing What works and what does not? Erika Matuschek, Ph D EUCAST Development Laboratory, EDL Methods for colistin testing What works and what does not? Erika Matuschek, Ph D EUCAST Development Laboratory, EDL 3 rd joint meeting on AMR in Salmonella and Campylobacter, Copenhagen 7 April 2017 Antimicrobial

More information

Discrepancies in the recovery of bacteria from multiple sinuses in acute and chronic sinusitis

Discrepancies in the recovery of bacteria from multiple sinuses in acute and chronic sinusitis Journal of Medical Microbiology (2004), 53, 879 885 DOI 10.1099/jmm.0.45655-0 Short Communication Correspondence Itzhak Brook ib6@georgetown.edu Received 1 March 2004 Accepted 18 May 2004 Discrepancies

More information

NETILMICIN SUMMARY OF PRECLINICAL MICROBIOLOGICAL STUDIES. G. H. MILLER, R. S. HARE, E. L. Moss, Jr., F. J. SABATELLI and J. A.

NETILMICIN SUMMARY OF PRECLINICAL MICROBIOLOGICAL STUDIES. G. H. MILLER, R. S. HARE, E. L. Moss, Jr., F. J. SABATELLI and J. A. NETILMICIN SUMMARY OF PRECLINICAL MICROBIOLOGICAL STUDIES G. H. MILLER, R. S. HARE, E. L. Moss, Jr., F. J. SABATELLI and J. A. WAITZ Departments of Chemotherapy and Antibiotic Research Schering Corporation

More information

PROTEUS-PROVIDENCIA-MORGANELLA GENERA

PROTEUS-PROVIDENCIA-MORGANELLA GENERA Gram-negative rods Proteus & Pseudomonas DR. HUDA ABO-ALEES 2014-2015 Objectives: Describe the morphology & physiology for Proteus & Pseudomonas. Determine the virulence factors of proteus and pseudomonas.

More information

Corynebacterium Group D2 as a Cause of Alkaline-Encrusted Cystitis: Report of Four Cases and Characterization of the Organisms

Corynebacterium Group D2 as a Cause of Alkaline-Encrusted Cystitis: Report of Four Cases and Characterization of the Organisms JOURNAL OF CLINICAL MICROBIOLOGY, May 1985, p. 788-792 95-1137/85/5788-5$2./ Copyright ) 1985, American Society for Microbiology ol. 21, No. S Corynebacterium Group D2 as a Cause of Alkaline-Encrusted

More information

What is new in EUCAST South Africa, May, Gunnar Kahlmeter EUCAST Technical Data Coordinator and Webmaster Sweden

What is new in EUCAST South Africa, May, Gunnar Kahlmeter EUCAST Technical Data Coordinator and Webmaster Sweden What is new in EUCAST 2016 17 South Africa, May, 2016 Gunnar Kahlmeter EUCAST Technical Data Coordinator and Webmaster Sweden What is new in EUCAST 2016/17? New organisms with breakpoints (Addendum 2016)

More information

Prevalence of asymptomatic bacteriuria in elderly referred to outpatient clinics in Talegani hospital, Abadan, Iran

Prevalence of asymptomatic bacteriuria in elderly referred to outpatient clinics in Talegani hospital, Abadan, Iran Farajzadeh Sheikh et al. 147 Original article Prevalence of asymptomatic bacteriuria in elderly referred to outpatient clinics in Talegani hospital, Abadan, Iran Ahmad Farajzadeh Sheikh, PhD 1 Nabi Jomehzadeh,

More information

THE SENSITIVITY OF STAPHYLOCOCCI AND OTHER WOUND BACTERIA TO ERYTHROMYCIN, OLEANDOMYCIN, AND SPIRAMYCIN

THE SENSITIVITY OF STAPHYLOCOCCI AND OTHER WOUND BACTERIA TO ERYTHROMYCIN, OLEANDOMYCIN, AND SPIRAMYCIN J. clin. Path. (1959), 12, 163. THE SENSITIVITY OF STAPHYLOCOCCI AND OTHER WOUND BACTERIA TO ERYTHROMYCIN, OLEANDOMYCIN, AND SPIRAMYCIN BY E. J. L. LOWBURY AND L. HURST From the Medical Research Council

More information

Chapter 4. Anti-bacterial studies of PUFA extracts from Sardinella longiceps and Sardinella fimbriata. 4.1 Introduction

Chapter 4. Anti-bacterial studies of PUFA extracts from Sardinella longiceps and Sardinella fimbriata. 4.1 Introduction Anti-bacterial studies of PUFA extracts from Sardinella longiceps and Sardinella fimbriata C o n t e n t s 4.1 Introduction 4.2 Materials and Methods 4.2.1 Extract Preparation and Determination of PUFA

More information

URINARY TRACT INFECTIONS IN DIABETIC PATIENTS ATTENDING OUTPATIENT DEPARTMENTS AT KASTURBA MEDICAL COLLEGE TEACHING HOSPITAL, MANIPAL, INDIA

URINARY TRACT INFECTIONS IN DIABETIC PATIENTS ATTENDING OUTPATIENT DEPARTMENTS AT KASTURBA MEDICAL COLLEGE TEACHING HOSPITAL, MANIPAL, INDIA WORLD JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES Gautam R. et al. Volume 2, Issue 3, 1141-1146. Research Article ISSN 2278 4357 URINARY TRACT INFECTIONS IN DIABETIC PATIENTS ATTENDING OUTPATIENT DEPARTMENTS

More information

Pseudomonas aeruginosa

Pseudomonas aeruginosa JOURNAL OF CLINICAL MICROBIOLOGY, July 1983, p. 16-164 95-1137/83/716-5$2./ Copyright C) 1983, American Society for Microbiology Vol. 18, No. 1 A Three-Year Study of Nosocomial Infections Associated with

More information

Association of Mucoid Encapsulated Moraxella duplex

Association of Mucoid Encapsulated Moraxella duplex APPLIED MICROBIOLOGY, Feb. 1968, p. 315-319 Copyright 1968 American Society for Microbiology Vol. 16, No. 2 Prinited int U.S.A. Association of Mucoid Encapsulated Moraxella duplex var. nonliquefaciens

More information

Public Health Surveillance for Multi Drug Resistant Organisms in Orange County

Public Health Surveillance for Multi Drug Resistant Organisms in Orange County Public Health Surveillance for Multi Drug Resistant Organisms in Orange County Matt Zahn, MD Medical Director Epidemiology and Assessment Orange County Public Health Antimicrobial Mechanisms of Action

More information

Effect of glucose and ph on uropathogenic and non-uropathogenic Escherichia coli: studies with urine from diabetic and non-diabetic individuals

Effect of glucose and ph on uropathogenic and non-uropathogenic Escherichia coli: studies with urine from diabetic and non-diabetic individuals J. Med. Microbiol. - Vol. 48 (1999), 535-539 0 1999 The athological Society of Great Britain and Ireland BACTERIAL ATHOGEN I CITY Effect of glucose and ph on uropathogenic and non-uropathogenic Escherichia

More information

Best Practice of in vitro Methods on Measuring Anti Microbial of Chemical Substance on Root Canal Treatment: Literature Review

Best Practice of in vitro Methods on Measuring Anti Microbial of Chemical Substance on Root Canal Treatment: Literature Review Best Practice of in vitro Methods on Measuring Anti Microbial of Chemical Substance on Root Canal Treatment: Literature Review Dani Rizali Firman 1, Indra Primathena 2 1 Oral Biology Department, Faculty

More information

Report on susceptibility of Salmonella serotypes in Belgium Vicky Jasson

Report on susceptibility of Salmonella serotypes in Belgium Vicky Jasson CODA-CERVA Report on susceptibility of Salmonella serotypes in Belgium 2014. Vicky Jasson Veterinary and Agrochemical Research Centre 1 Introduction Salmonella is one of the most important bacterial zoonotic

More information

JAC Efficacy and tolerance of roxithromycin versus clarithromycin in the treatment of lower respiratory tract infections

JAC Efficacy and tolerance of roxithromycin versus clarithromycin in the treatment of lower respiratory tract infections Journal of Antimicrobial Chemotherapy (1998) 41, Suppl. B, 69 73 JAC Efficacy and tolerance of roxithromycin versus clarithromycin in the treatment of lower respiratory tract infections G. Tatsis*, G.

More information

The Effect of Cranberry Juice and Cranberry Derivatives on the Hemagglutination Activity of P-Fimbriated Escherichia coli

The Effect of Cranberry Juice and Cranberry Derivatives on the Hemagglutination Activity of P-Fimbriated Escherichia coli THE EFFECT OF CRANBERRY JUICE AND CRANBERRY DERIVATIVES ON THE HEMAGGLUTINATION ACTIVITY OF P-FIMBRIATED ESCHERICHIA COLI 409 The Effect of Cranberry Juice and Cranberry Derivatives on the Hemagglutination

More information

Treatment of Bacterial Meningitis with Intravenous

Treatment of Bacterial Meningitis with Intravenous ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Aug. 1979, p. 171-175 0066-4804/79/08-0171/05$02.00/0 Vol. 16, No. 2 Treatment of Bacterial Meningitis with Intravenous Amoxicillin CHARLES M. NOLAN,`* ELIAS G. CHALHUB,2,

More information

EUCAST Frequently Asked Questions. by author. Rafael Cantón Hospital Universitario Ramón y Cajal, Madrid, Spain EUCAST Clinical Data Coordinator

EUCAST Frequently Asked Questions. by author. Rafael Cantón Hospital Universitario Ramón y Cajal, Madrid, Spain EUCAST Clinical Data Coordinator EUCAST Frequently Asked Questions Rafael Cantón Hospital Universitario Ramón y Cajal, Madrid, Spain EUCAST Clinical Data Coordinator Erika Matuschek EUCAST Development Laboratory, Växjö Sweden Monday 24

More information

Urine bench. John Ferguson Sept 2013

Urine bench. John Ferguson Sept 2013 Urine bench John Ferguson Sept 2013 Overview Specimen collection- separate presentation Urinalysis: protein, blood, white cells, nitrite Microscopy- crystals and casts- separate presentations quantitative

More information

Sensitive and specific Modified Hodge Test for KPC and metallo-beta-lactamase

Sensitive and specific Modified Hodge Test for KPC and metallo-beta-lactamase JCM Accepts, published online ahead of print on 19 October 2011 J. Clin. Microbiol. doi:10.1128/jcm.05602-11 Copyright 2011, American Society for Microbiology and/or the Listed Authors/Institutions. All

More information

KEFZOL (cephazolin, as cephazolin sodium)

KEFZOL (cephazolin, as cephazolin sodium) PRODUCT INFORMATION KEFZOL (cephazolin, as cephazolin sodium) DESCRIPTION Kefzol (cephazolin sodium) is a semisynthetic cephalosporin for parenteral administration. It is the sodium salt of 3-[[(5-methyl-1,3,4-thiadiazol-2-yl)-thio]

More information

Serotyping and the Dienes reaction on Proteus

Serotyping and the Dienes reaction on Proteus J. clin. Path. (199), 22, 2-28 Serotyping and the Dienes reaction on Proteus mirabilis from hospital infections J. de LOUVOIS1 From the Department ofpathology, Midland Centre for Neurosurgery and Neurology,

More information

Laboratory CLSI M100-S18 update. Paul D. Fey, Ph.D. Associate Professor/Associate Director Josh Rowland, M.T. (ASCP) State Training Coordinator

Laboratory CLSI M100-S18 update. Paul D. Fey, Ph.D. Associate Professor/Associate Director Josh Rowland, M.T. (ASCP) State Training Coordinator Nebraska Public Health Laboratory 2008 CLSI M100-S18 update Paul D. Fey, Ph.D. Associate Professor/Associate Director Josh Rowland, M.T. (ASCP) State Training Coordinator Agenda Discuss 2008 M100- S18

More information

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS The European Agency for the Evaluation of Medicinal Products Veterinary Medicines Evaluation Unit EMEA/MRL/0128/96-FINAL July 1996 COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS CEFAPIRIN SUMMARY REPORT (1)

More information

Mesporin TM. Ceftriaxone sodium. Rapid onset, sustained action, for a broad spectrum of infections

Mesporin TM. Ceftriaxone sodium. Rapid onset, sustained action, for a broad spectrum of infections Ceftriaxone sodium Rapid onset, sustained action, for a broad spectrum of infections 1, 2, 3 Antibiotic with a broad spectrum of activity Broad spectrum of activity against gram-positive* and gram-negative

More information

Guidance on screening and confirmation of carbapenem resistant Enterobacteriacae (CRE) December 12, 2011

Guidance on screening and confirmation of carbapenem resistant Enterobacteriacae (CRE) December 12, 2011 Guidance on screening and confirmation of carbapenem resistant Enterobacteriacae (CRE) December 12, 2011 Objectives: To discuss the guidelines for detection of CRE in the laboratory setting. To review

More information

Antimicrobial activity of some medicinal plants against multidrug resistant skin pathogens

Antimicrobial activity of some medicinal plants against multidrug resistant skin pathogens Journal of Medicinal Plants Research Vol. 5(16), pp. 3856-3860, 18 August, 2011 Available online at http://www.academicjournals.org/jmpr ISSN 1996-0875 2011 Academic Journals Full Length Research Paper

More information

EVALUATION OF METHODS FOR AMPC β-lactamase IN GRAM NEGATIVE CLINICAL ISOLATES FROM TERTIARY CARE HOSPITALS

EVALUATION OF METHODS FOR AMPC β-lactamase IN GRAM NEGATIVE CLINICAL ISOLATES FROM TERTIARY CARE HOSPITALS Indian Journal of Medical Microbiology, (2005) 23 (2):120-124 Brief Communication EVALUATION OF METHODS FOR AMPC β-lactamase IN GRAM NEGATIVE CLINICAL ISOLATES FROM TERTIARY CARE HOSPITALS S Singhal, T

More information

Screening of Chinese Medicinal Herbs for the Inhibition of Brucella melitensis

Screening of Chinese Medicinal Herbs for the Inhibition of Brucella melitensis 5 th Proceedings of the Seminar in Veterinary Sciences, 5-8 January 2010 Screening of Chinese Medicinal for the Inhibition of Khoo Wen Wen & 1 Siti Khairani Bejo 1 Department of Veterinary Pathology and

More information

Antiseptic and antibiotic resistance in Gram-negative bacteria causing urinary tract infection

Antiseptic and antibiotic resistance in Gram-negative bacteria causing urinary tract infection J Clin Patho/ 198; 33: 288-296 Antiseptic and antibiotic resistance in Gram-negative bacteria causing urinary tract infection DJ STICKLER AND B THOMAS From the Department of Applied Biology, University

More information

Natural History of Aortic Valve Endocarditis in Rats

Natural History of Aortic Valve Endocarditis in Rats INFECTION AND IMMUNITY, JUlY 192, p. 127-131 19-9567/2/7127-5$2./ Vol. 37, No. 1 Natural History of Aortic Valve Endocarditis in Rats ERIC HtRAIEF, MICHEL P. GLAUSER,* AND LAWRENCE R. FREEDMANt Division

More information

St. Joseph's Journal of Humanities and Science ISSN:

St. Joseph's Journal of Humanities and Science ISSN: M. Parimala Celia et al. / St. Joseph s Journal of Humanities and Science (Volume 4 Issue 1 January 2017) 23-28 33 St. Joseph s Journal of Humanities and Science (Volume 4 Issue 2 August 2015) 33-38 St.

More information

Surveillance of antimicrobial susceptibility of Enterobacteriaceae pathogens isolated from intensive care units and surgical units in Russia

Surveillance of antimicrobial susceptibility of Enterobacteriaceae pathogens isolated from intensive care units and surgical units in Russia Feb. 2016 THE JAPANESE JOURNAL OF ANTIBIOTICS 69 1 41 41 Surveillance of antimicrobial susceptibility of Enterobacteriaceae pathogens isolated from intensive care units and surgical units in Russia IRINA

More information

Pharmacokinetics and Bacteriological Efficacy of Moxalactam

Pharmacokinetics and Bacteriological Efficacy of Moxalactam ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Mar. 1980, p. 406-411 0066-4804/80/03-0406/06$020/0 Vol. 17, No. 3 Pharmacokinetics and Bacteriological Efficacy of Moxalactam (LY127935), Netilmicin, and Ampicillin

More information

Comparison of Anti- Vibrio Activities of Potassium Sorbate, Sodium Benzoate, and Glycerol and Sucrose Esters of Fatty

Comparison of Anti- Vibrio Activities of Potassium Sorbate, Sodium Benzoate, and Glycerol and Sucrose Esters of Fatty APPLIED AND ENVIRONMENTAL MICROBIOLOGY, June 1980, p. 1178-1182 0099-2240/80/06-1178/05$02.00/0 Vol. 39, No. 6 Comparison of Anti- Vibrio Activities of Potassium Sorbate, Sodium Benzoate, and Glycerol

More information

AXITAB-CV TAB. COMPOSITION :

AXITAB-CV TAB. COMPOSITION : AXITAB-CV TAB. COMPOSITION : Each film coated tablet contains: Cefuroxime Axetil I.P. Eq. to Anhydrous 500mg. Potassium Clavulanate Diluted I.P. Eq. to Clavulanic Acid 125mg DESCRIPTION : Cefuroxime Axetil

More information

Bacteriological Profile of Post Traumatic Osteomyelitis in a Tertiary Care Centre

Bacteriological Profile of Post Traumatic Osteomyelitis in a Tertiary Care Centre International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 6 Number 1 (2017) pp. 367-372 Journal homepage: http://www.ijcmas.com Original Research Article http://dx.doi.org/10.20546/ijcmas.2017.601.044

More information

Urinary tract infection, Urinary pathogens.

Urinary tract infection, Urinary pathogens. Kay words: Urinary tract infection, Urinary pathogens. Fig. 1 Organisms commonly isolated and their incidence in the U.T.I. with bacterial TOTAL(NUMBER=1396) MALE(NUMBER=707) FEMALE(NUMBER=689) Fig. 2

More information

VANCOCIN CAPSULES (vancomycin hydrochloride)

VANCOCIN CAPSULES (vancomycin hydrochloride) PRODUCT INFORMATION VANCOCIN CAPSULES (vancomycin hydrochloride) This preparation for the treatment of colitis is for oral use only. Vancocin must be given orally for treatment of staphylococcal enterocolitis

More information